DNM1L and pulmonary fibrosis: Furthermore, JTE-013 demonstrated efficacy in improving mitochondrial dysfunction, a consequence of pulmonary fibrosis, primarily by modulating the expression of mitochondrial fission protein Drp1 and fusion protein MFN, reducing oxidative stress levels, and enhancing apoptosis.